Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis-Reference-Cited by-同舟云学术

Nonclinical Models for Antituberculosis Drug Development: A Landscape Analysis

Published:2015-05-25 Issue:suppl 3 Volume:211 Page:S83-S95
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:J Infect Dis.

Author:

Gumbo Tawanda,Lenaerts Anne J.,Hanna Debra,Romero Klaus,Nuermberger Eric

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/211/suppl_3/S83/5106991/jiv183.pdf

Reference135 articles.

1. Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia

2. Heifets LB . Antituberculosis drugs: Antimicrobial activity in vitro. In: Heifets LB , ed. Drug susceptibility in the chemotherapy of mycobacterial infections. 1st ed. Boca Raton, FL: CRC Press, 1991:13–57.

3. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis

4. Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore

5. An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of antibiotic-specificMycobacterium tuberculosisphenotypes during prolonged treatment of mice;2024-08-21

2. Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis;2024-05-13

3. Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis;Antimicrobial Agents and Chemotherapy;2024-05-02

4. 3D Hydrogel Culture System Recapitulates Key Tuberculosis Phenotypes and Demonstrates Pyrazinamide Efficacy;Advanced Healthcare Materials;2024-05

5. Evaluation of critical parameters in the hollow‐fibre system for tuberculosis: A case study of moxifloxacin;British Journal of Clinical Pharmacology;2024-04-17